Showing results (11-20 of 118) with videos related to
Sort By:
Pageof 12
Trials|April 21, 2018
Stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trialsKelly F J Stewart, Anke Wesselius, Annemie M W J Schols, et al.Cancer Epidemiology|June 28, 2025
The associations between sleep-related factors and bladder cancer: A cross-sectional study in the UK BiobankYiming Chen, Enyu Tong, Yufeng Rao, et al.Frontiers in Bioscience (Scholar Edition)|May 31, 2011
P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammationMartijn Jan Leo Bours, Pieter Cornelis Dagnelie, Anna Lisa Giuliani, et al.BMC Public Health|January 12, 2022
Dietary patterns and risk of bladder cancer: a systematic review and meta-analysisMostafa Dianatinasab, Elaheh Forozani, Ali Akbari, et al.Frontiers in Bioscience (Landmark Edition)|May 31, 2011
Role of purinergic receptor polymorphisms in human boneAnke Wesselius, Martijn J L Bours, Ankita Agrawal, et al.Journal of Community Genetics|July 1, 2017
Behavioural changes, sharing behaviour and psychological responses after receiving direct-to-consumer genetic test results: a systematic review and meta-analysisKelly F J Stewart, Anke Wesselius, Maartje A C Schreurs, et al.Journal of Community Genetics|January 3, 2018
Correction to: Behavioural changes, sharing behaviour and psychological responses after receiving direct-to-consumer genetic test results:a systematic review and meta-analysisKelly F J Stewart, Anke Wesselius, Maartje A C Schreurs, et al.European Journal of Epidemiology|March 23, 2016
Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analysesAbdulmohsen H Al-Zalabani, Kelly F J Stewart, Anke Wesselius, et al.Hepatology (Baltimore, Md.)|April 20, 2022
Relationship between NAFLD and coronary artery disease: A Mendelian randomization studyZhewen Ren, Pomme I H G Simons, Anke Wesselius, et al.BMC Immunology|December 6, 2012
The P2X(7) loss-of-function Glu496Ala polymorphism affects ex vivo cytokine release and protects against the cytotoxic effects of high ATP-levelsAnke Wesselius, Martijn J L Bours, Ilja C W Arts, et al.Pageof 12